Clinical trial
Study to Describe the Allergic Reactions to Factor IX in Patients With…
NCT00195221 · Wyeth is now a wholly owned subsidiary of Pfizer, Industry · Completed
Key facts
| NCT number | NCT00195221 |
|---|---|
| Title | Study to Describe the Allergic Reactions to Factor IX in Patients With Hemophilia B |
| Official title | A Retrospective Study to Describe the Incidence of Moderate to Severe Allergic Reactions to Factor IX in Patients With Hemophilia B |
| Lead sponsor | Wyeth is now a wholly owned subsidiary of Pfizer, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Hemophilia B, Allergic Reactions |
| Enrollment | 166 |
| Start date | Feb 1, 2005 |
| Completion | Nov 1, 2007 |
| First posted | Sep 19, 2005 |
| Last update posted | Dec 5, 2007 |
| Countries | Austria, Belgium, Canada, France, Germany, Italy, Spain, United Kingdom, United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: